Literature DB >> 11443195

Antigonadotropic action of adenosine triphosphate in human granulosa-luteal cells: involvement of protein kinase Calpha.

C J Tai1, S K Kang, K C Choi, C R Tzeng, P C Leung.   

Abstract

The presence of P2U purinoceptor in human granulosa-luteal cells (hGLCs) indicates a potential role of ATP in regulating ovarian function. In this study an inhibitory effect of ATP on hCG-induced cAMP production was observed. Extracellular ATP has been shown to activate protein kinase C (PKC) after binding to a purinoceptor. To understand the role of PKC in mediating ATP action, hCG-stimulated cAMP level was examined in the presence of the PKC activator, 1 micromol/L phorbol 12-myristate 13-acetate (PMA), or the PKC inhibitor, 1 micromol/L staurosporin or 1 micromol/L bisindolylmaleimide I. PMA, like 10 micromol/L ATP, significantly reduced hCG-evoked cAMP production. In addition, the inhibitory effect of ATP was reversed by staurosporin and bisindolylmaleimide I. To further investigate the involvement of PKC isoforms in mediating the inhibitory effect of ATP, the presence of PKC isoforms in cultured hGLCs was examined by Western blot using monoclonal antibodies against specific isoforms. Translocation of PKC isoforms from cytosolic fraction to membrane fraction was studied to identify the active PKC isozymes subsequent to ATP treatment. The change in PKC isoform in PKC-depleted cells (achieved by exposure to PMA for 18 h) was also examined. Our results demonstrated the presence of PKCalpha, -delta, -iota, and -lambda isoforms in hGLCs and the translocation of PKCalpha subsequent to ATP treatment. In PKC-depleted cells the PKCalpha level was reduced, and no significant effect of ATP on hCG-stimulated cAMP production was observed. To our knowledge, this is the first demonstration of PKC isoforms in hGLCs and the involvement of activated PKC in mediating the antigonadotropic effect of extracellular ATP. Taken together, these results further support a role of this neurotransmitter in regulating human ovarian function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443195     DOI: 10.1210/jcem.86.7.7691

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

Review 2.  Purinergic signaling pathways in endocrine system.

Authors:  Ivana Bjelobaba; Marija M Janjic; Stanko S Stojilkovic
Journal:  Auton Neurosci       Date:  2015-04-25       Impact factor: 3.145

3.  A proteomic analysis of IVF follicular fluid in women <or=32 years old.

Authors:  Stephanie J Estes; Bin Ye; Weiliang Qiu; Daniel Cramer; Mark D Hornstein; Stacey A Missmer
Journal:  Fertil Steril       Date:  2008-11-05       Impact factor: 7.329

Review 4.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

5.  Functional expression and intracellular signaling of UTP-sensitive P2Y receptors in theca-interstitial cells.

Authors:  Francisco G Vázquez-Cuevas; Erika P Zárate-Díaz; Edith Garay; Rogelio O Arellano
Journal:  Reprod Biol Endocrinol       Date:  2010-07-14       Impact factor: 5.211

6.  Protein kinase C isoforms α, δ and ε are differentially expressed in mouse ovaries at different stages of postnatal development.

Authors:  Filiz Tepekoy; Ismail Ustunel; Gokhan Akkoyunlu
Journal:  J Ovarian Res       Date:  2014-12-10       Impact factor: 4.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.